Meeder Asset Management’s Medicines Co MDCO Stock Holding History

Meeder Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-3,960	Closed	-$197K	–	2532
2019 Q3	$197K	Buy	3,960 +2,765	+231%	+$110K	0.01%	609
2019 Q2	$44K	Buy	+1,195	New	+$39K	﹤0.01%	988
2016 Q1	–	Sell	-381	Closed	-$14K	–	969
2015 Q4	$14K	Buy	+381	New	+$14.4K	﹤0.01%	754

Other funds holding MDCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Meeder Asset Management's MDCO Position: Q4 2019 in Review

Meeder Asset Management sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 3,960 shares — an estimated $197K sold.

Meeder Asset Management first reported a position in MDCO in Q4 2015 and held it in 3 quarters. The position peaked at $197K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

Meeder Asset Management reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
Meeder Asset Management sold 3,960 Medicines Co shares in Q4 2019, an estimated $197K.
Meeder Asset Management first reported a position in Medicines Co in Q4 2015 and held it in 3 quarters.
Meeder Asset Management's Medicines Co position peaked at $197K in Q3 2019.
284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Meeder Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.